Partner Ryan Million, with a team from Trinity Partners, along with Amgen and Wade Outcomes Research and Consulting have published an article in Clinical Epidemiology. The article, titled: Prevalence of bone metastases and bone-targeting agent use among solid tumor patients in the United States, discusses the results of a study undertaken to estimate the prevalence of bone metastases from solid tumors and to describe recent trends in the use of BTA in the United States. The study concluded that of the estimated 333,000 solid tumor patients living with bone metastases in the US in 2012, many may have received less than optimal care to prevent bone complications during the calendar year.
In addition to Dr. Million, the team from Trinity Partners who contributed to the article were: Kevin Francis, Avanti Adhia, and Hasmik Alvrtsyan.
To view the full text of the article, please visit: http://www.dovepress.com/prevalence-of-bone-metastases-and-bone-targeting-agent-use-among-solid-peer-reviewed-fulltext-article-CLEP#
To learn more about Dr. Ryan Million, and our other partners, please click here
To see our other publications, please click here